Domů › Nádory mozku › New York › New York City
Klinické studie Nádory mozku v New York City, NY
25 studií pro Nádory mozku hledá účastníky v lokalitách v New York City a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma
Probíhá náborFáze 2
- New York University Langone's Perlmutter Cancer Institute, New York
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
Probíhá náborFáze 2
- Columbia University Irving Medical Center, New York
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Probíhá náborFáze 1/2
- NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
- Memorial Sloan Kettering Cancer Center, New York
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
Probíhá náborFáze 2
- Local Institution - 0170, New York
- Memorial Sloan Kettering Cancer Center, New York
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Probíhá náborFáze 1
- Icahn School of Medicine at Mount Sinai, New York
A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
Probíhá náborFáze 2
- Memorial Sloan-Kettering Cancer Center, New York
Chronic CED of TPT for Recurrent Malignant Glioma
Probíhá náborFáze 1
- Columbia University Irving Medical Center / NewYork-Presbyterian Hospital, New York
A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain
Probíhá náborFáze 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
European Prospective Investigation Into Childhood Cancer
Probíhá náborObservační studie
- Columbia University Irving Medical Center, New York
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
Probíhá náborFáze 1/2
- Lenox Hill Brain Tumor Center, New York
Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM
Probíhá náborFáze 3
- Lenox Hill Brain Tumor Center, New York
Surgical Tissue Flap to Bypass the Blood Brain Barrier in Glioblastoma
Probíhá nábor
- Lenox Hill Brain Tumor Center, New York
Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM)
Probíhá nábor
- Lenox Hill Brain Tumor Center, New York
Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
Probíhá náborFáze 1/2
- Lenox Hill Brain Tumor Center, New York
A Study of Sotorasib in People With Brain Tumors
Probíhá náborFáze 1
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Brodalumab in the Treatment of Immune-Related Adverse Events
Probíhá náborFáze 1
- Columbia University Irving Medical Center, New York
rTMS for Postoperative Brain Tumor Patients
Probíhá nábor
- Columbia University Irving Medical Center, New York
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Probíhá náborFáze 1/2
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
Probíhá náborFáze 2
- Lenox Hill Brain Tumor Center, New York
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
Probíhá náborFáze 1/2
- Weill Cornell Medicine, New York
- Brooklyn Methodist Hospital - NewYork Presbyterian, New York
- New York Presbyterian Hospital - Queens, New York
Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment
Probíhá náborObservační studieVítáni zdraví dobrovolníci
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer
Probíhá náborFáze 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
FUS Etoposide for DMG
Probíhá náborFáze 1
- Columbia University Irving Medical Center, New York
Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer
Probíhá náborFáze 4
- New York-Presbyterian/Weill Cornell Medical Center, New York
Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors
Probíhá nábor
- Memorial Sloan Kettering Cancer Center, New York
Studie Nádory mozku v jiných městech
- Houston, TX35 studií
- Boston, MA28 studií
- Washington, DC20 studií
- Los Angeles, CA16 studií
- Miami, FL15 studií
- Durham, NC14 studií
- St. Louis, MO12 studií
- Rochester, MN11 studií
- Chicago, IL11 studií
- Cleveland, OH11 studií
- Baltimore, MD11 studií
- Columbus, OH11 studií
Další studie v New York City
- Rakovina prsu136 studií
- Nemalobuněčný plicní karcinom121 studií
- Rakovina (všechny typy)109 studií
- Rakovina prostaty103 studií
- Metastatický karcinom93 studií
- Kolorektální karcinom78 studií
- Rakovina vaječníků69 studií
- Rakovina plic60 studií
- Mnohočetný myelom60 studií
- Rakovina slinivky břišní60 studií
- Rakovina endometria52 studií
- Akutní myeloidní leukemie51 studií
Zdroj: ClinicalTrials.gov, data načtena 6. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.